Background: Cardiac Amyloidosis (CA) is a condition caused by the deposition of amyloid fibrils in the heart. The diagnosis of CA can be challenging and requires a high index of suspicion. Multimodality imaging, including echocardiography and Cardiac Magnetic Resonance (CMR), plays a crucial role in the diagnosis, eval...
Yosua Cristo Reynaldo Napitupulu, H. A. P. Lubis, C. A. Andra et al.· Indonesian Journal of Cardio...· 0 citations
In preserved-EF patients, LARS decreases with increasing CAD severity and differentiates CAD burden better than conventional LV structural and functional parameters, supporting its potential utility as a non-invasive marker of CAD severity.
G. Justisia, A. P. Ketaren, C. A. Andra· European Heart Journal, Supp...· 0 citations
Background: The Global Registry of Acute Coronary Events (GRACE) score is widely used for risk stratification in patients with non–ST-elevation myocardial infarction (NSTEMI). However, it does not account for metabolic factors such as insulin resistance, which may contribute to residual cardiovascular risk. The triglyc...
F. Zahra, C. A. Andra, A. H. Raynaldo et al.· Journal of the Hong Kong Col...· 0 citations
BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) remains a major cause of cardiovascular morbidity. While guideline-directed medical therapy, including Angiotensin Receptor Neprylisin Inhibitor (ARNI) dan Angiotensin Converting Enzyme-Inhibitor (ACE-I)/Angiotensin Receptor Blocker (ARB), is well-establi...
Grace Nikensari, C. A. Andra, Ali Nafiah Nasution et al.· Journal of Endocrinology, Tr...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.